Sign up Australia
Proactive Investors - Run By Investors For Investors

WAM Global raises well over $330 million for its upcoming IPO

WAM Global shares are expected to list on ASX as part of the IPO on 22 June 2018.
electronic ASX board
WAM Global Limited shares will have a listing price of $2.20

WAM Global Ltd (ASX:WGB) is now accepting oversubscriptions of up to $220 million after it exceeded the $330 million mark for its initial public offering (IPO).

The listed investment company (LIC) is set to close the broker firm offer this Friday ahead of its debut on the ASX.

Part of the Wilson Asset Management family

Funds raised under the WAM Global IPO will be managed by investment manager Wilson Asset Management, which has a 20-year track record.

Wilson Asset Management is the investment manager for six leading listed investment companies; WAM Capital Ltd (ASX:WAM), WAM Leaders Ltd (ASX:WLE), WAM Microcap Ltd (ASX:WMI), WAM Research Ltd (ASX:WAX), WAM Active Ltd (ASX:WAA) and Century Australia Ltd (ASX:CYA).

Through these LICs, Wilson Asset Management invests more than $3 billion on behalf of more than 55,000 retail investors.

WAM Global will have an international focus

WAM Global’s investment objectives are to provide capital growth over the medium-to-long term, deliver a stream of fully franked dividends and preserve capital while providing shareholders with exposure to global equities.

It will focus on undervalued international growth companies with a bias to small-medium sized entities, utilise a portfolio based and index unaware investment methodology and preserve shareholders’ capital.

Timetable expected ASX listing on 22 June

Upcoming important dates for the offer include:

• Broker firm offer expected to close - 1 June 2018;
• Priority and general offer expected to close - 8 June 2018; and
• WAM Global shares expected to list on ASX - 22 June 2018.

View full . profile View Profile

Proactive Investors Australia Timeline

Related Articles

Students in a class
August 27 2018
The company is gaining traction in Asia where people are looking to take language courses to work or study internationally
Clint Eastwood
May 25 2018
The group’s first piece of original content, a documentary called Pandas, premiered on 24 March this year, to positive reviews.
September 20 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use